161 related articles for article (PubMed ID: 16093430)
1. Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer.
Younes MN; Kim S; Yigitbasi OG; Mandal M; Jasser SA; Dakak Yazici Y; Schiff BA; El-Naggar A; Bekele BN; Mills GB; Myers JN
Mol Cancer Ther; 2005 Aug; 4(8):1146-56. PubMed ID: 16093430
[TBL] [Abstract][Full Text] [Related]
2. Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).
Edwards LA; Woo J; Huxham LA; Verreault M; Dragowska WH; Chiu G; Rajput A; Kyle AH; Kalra J; Yapp D; Yan H; Minchinton AI; Huntsman D; Daynard T; Waterhouse DN; Thiessen B; Dedhar S; Bally MB
Mol Cancer Ther; 2008 Jan; 7(1):59-70. PubMed ID: 18202010
[TBL] [Abstract][Full Text] [Related]
3. Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.
Younes MN; Yigitbasi OG; Yazici YD; Jasser SA; Bucana CD; El-Naggar AK; Mills GB; Myers JN
Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):15-23. PubMed ID: 17224516
[TBL] [Abstract][Full Text] [Related]
4. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
Koul D; Shen R; Bergh S; Lu Y; de Groot JF; Liu TJ; Mills GB; Yung WK
Mol Cancer Ther; 2005 Nov; 4(11):1681-8. PubMed ID: 16275989
[TBL] [Abstract][Full Text] [Related]
5. QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model.
Kalra J; Warburton C; Fang K; Edwards L; Daynard T; Waterhouse D; Dragowska W; Sutherland BW; Dedhar S; Gelmon K; Bally M
Breast Cancer Res; 2009; 11(3):R25. PubMed ID: 19409087
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer.
Wunderlich A; Fischer M; Schlosshauer T; Ramaswamy A; Greene BH; Brendel C; Doll D; Bartsch D; Hoffmann S
Cancer Sci; 2011 Apr; 102(4):762-8. PubMed ID: 21214672
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts.
Yau CY; Wheeler JJ; Sutton KL; Hedley DW
Cancer Res; 2005 Feb; 65(4):1497-504. PubMed ID: 15735038
[TBL] [Abstract][Full Text] [Related]
8. Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation.
Younes MN; Yigitbasi OG; Park YW; Kim SJ; Jasser SA; Hawthorne VS; Yazici YD; Mandal M; Bekele BN; Bucana CD; Fidler IJ; Myers JN
Cancer Res; 2005 Jun; 65(11):4716-27. PubMed ID: 15930290
[TBL] [Abstract][Full Text] [Related]
9. Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo Model of Cancer.
Kalra J; Dragowska WH; Bally MB
J Histochem Cytochem; 2015 Sep; 63(9):691-709. PubMed ID: 25940338
[TBL] [Abstract][Full Text] [Related]
10. Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target.
Shirley LA; McCarty S; Yang MC; Saji M; Zhang X; Phay J; Ringel MD; Chen CS
Surgery; 2016 Jan; 159(1):163-70. PubMed ID: 26549818
[TBL] [Abstract][Full Text] [Related]
11. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
[TBL] [Abstract][Full Text] [Related]
12. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
13. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
14. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor.
Kaneko Y; Kitazato K; Basaki Y
J Cell Sci; 2004 Jan; 117(Pt 3):407-15. PubMed ID: 14679308
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
[TBL] [Abstract][Full Text] [Related]
16. The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck.
Eke I; Leonhardt F; Storch K; Hehlgans S; Cordes N
PLoS One; 2009 Jul; 4(7):e6434. PubMed ID: 19649326
[TBL] [Abstract][Full Text] [Related]
17. Role of integrin-linked kinase in nerve growth factor-stimulated neurite outgrowth.
Mills J; Digicaylioglu M; Legg AT; Young CE; Young SS; Barr AM; Fletcher L; O'Connor TP; Dedhar S
J Neurosci; 2003 Mar; 23(5):1638-48. PubMed ID: 12629168
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines.
Nobuhara Y; Onoda N; Yamashita Y; Yamasaki M; Ogisawa K; Takashima T; Ishikawa T; Hirakawa K
Br J Cancer; 2005 Mar; 92(6):1110-6. PubMed ID: 15785737
[TBL] [Abstract][Full Text] [Related]
19. The integrin-linked kinase (ILK) suppresses anoikis.
Attwell S; Roskelley C; Dedhar S
Oncogene; 2000 Aug; 19(33):3811-5. PubMed ID: 10949937
[TBL] [Abstract][Full Text] [Related]
20. Regulation of tumor angiogenesis by integrin-linked kinase (ILK).
Tan C; Cruet-Hennequart S; Troussard A; Fazli L; Costello P; Sutton K; Wheeler J; Gleave M; Sanghera J; Dedhar S
Cancer Cell; 2004 Jan; 5(1):79-90. PubMed ID: 14749128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
